# neurological disorders (blogs) — RSS Amplifier Recent posts from the 1 feeds in the RSS Amplifier directory that cover neurological disorders. Page: Feed: --- ## [The cost of waiting: what licensing a biotech asset early really saves you](https://www.labiotech.eu/opinion/cost-of-waiting-licensing-biotech-asset-early/) _2026-08-21 · Dylan Kissane · Labiotech.eu_ In recent years, biopharma has paid significantly different prices for the same underlying technology. In March 2025, AstraZeneca agreed to pay EsoBiotec, an in vivo CAR-T platform with early single-patient data, $425 million upfront and up to $575 million more in milestones. In August 2025, Gilead’s Kite paid $350 million for Interius BioTherapeutics, another in vivo CAR-T platform, also… ## [Beyond biology: Nanobiotix’s physics-first approach to cancer](https://www.labiotech.eu/podcast/beyond-biology-nanobiotixs-physics-first-approach-to-cancer/) _2026-08-21 · Jules Adam · Labiotech.eu_ What if the key to beating cancer was a new way of thinking about matter? That's the question Laurent Lévy asked when he co-founded Nanobiotix over twenty years ago The post Beyond biology: Nanobiotix’s physics-first approach to cancer appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from… ## [Life science industry in Geneva on a roll](https://www.labiotech.eu/in-depth/life-science-industry-in-geneva-on-a-roll/) _2026-08-19 · Roohi Mariam Peter · Labiotech.eu_ Geneva’s life science industry is bound to western Switzerland's Health Valley ecosystem but is also growing in and of itself. The post Life science industry in Geneva on a roll appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited.… ## [BIO-Europe 2026: Expanding the scope at Europe’s leading biotech partnering event](https://www.labiotech.eu/partner/bio-europe-2026-partnering-event/) _2026-08-18 · Vyara Siteva · Labiotech.eu_ BIO-Europe 2026 heads to Cologne this November, expanding from three tracks to seven to reach the full biotech and pharma C-suite. The post BIO-Europe 2026: Expanding the scope at Europe’s leading biotech partnering event appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s… ## [Eight biotech companies in Melbourne you should know about](https://www.labiotech.eu/best-biotech/biotech-companies-melbourne/) _2026-08-17 · Roohi Mariam Peter · Labiotech.eu_ Discover 8 biotech companies in Melbourne, ranging from commercial to preclinical-stage companies, advancing promising technologies. The post Eight biotech companies in Melbourne you should know about appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is… ## [We asked, you answered: Labiotech’s 2026 reader survey results](https://www.labiotech.eu/inside-labiotech/labiotech-2026-reader-survey-results/) _2026-08-14 · Dylan Kissane · Labiotech.eu_ Labiotech's reader survey reveals what our audience wants, needs, and is interested in for 2026. The post We asked, you answered: Labiotech’s 2026 reader survey results appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and… ## [How Cancer Research Horizons is building the future of childhood cancer medicines](https://www.labiotech.eu/podcast/how-cancer-research-horizons-is-building-the-future-of-childhood-cancer-medicines/) _2026-08-14 · Roohi Mariam Peter · Labiotech.eu_ Cancer Research Horizons' CBO Tony Hickson discusses why charity and pharma need each other now more than ever. The post How Cancer Research Horizons is building the future of childhood cancer medicines appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is… ## [UCB’s pipeline strategy in 2026: Doubling down on immunology and neurology](https://www.labiotech.eu/top-pharma-strategy/ucb-pipeline-strategy/) _2026-08-12 · Willow Shah-Neville · Labiotech.eu_ Discover how UCB’s pipeline strategy in 2026 is still focused on its core areas of immunology and neurology. The post UCB’s pipeline strategy in 2026: Doubling down on immunology and neurology appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly… ## [Seven biotechs driving progress in Duchenne muscular dystrophy](https://www.labiotech.eu/best-biotech/biotechs-driving-progress-duchenne-muscular-dystrophy/) _2026-08-11 · Roohi Mariam Peter · Labiotech.eu_ In this article, we take a look at seven clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space. The post Seven biotechs driving progress in Duchenne muscular dystrophy appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author… ## [We asked 19 biotech leaders what breaks their deals. It wasn’t the science.](https://www.labiotech.eu/expert-advice/cbo-ceo-relationship-biotech/) _2026-08-10 · Dylan Kissane · Labiotech.eu_ The CBO CEO relationship shapes biotech deal success. Discover insights from 19 industry leaders on board alignment and partnering. The post We asked 19 biotech leaders what breaks their deals. It wasn’t the science. appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author… ## [Finnish Seedboxes — Up to 20Gbps (Sponsored)](https://crawlproof.com/a/zz2iUeRUJGDS) _2026-08-10 · **Sponsored**_ Private Finnish seedboxes with 1–20Gbps speeds, RAID storage and 14‑day refund ## [Top biotech deals in July 2026](https://www.labiotech.eu/trends-news/biotech-deals-july-2026/) _2026-08-07 · Roohi Mariam Peter · Labiotech.eu_ The top biotech deals of July 2026 were over small molecules, cell therapies, antibodies, RNA therapeutics, vaccines, and AI. The post Top biotech deals in July 2026 appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and… ## [Why Western pharma is sleeping on China’s circular RNA revolution](https://www.labiotech.eu/podcast/why-western-pharma-is-sleeping-on-chinas-circular-rna-revolution/) _2026-08-07 · Roohi Mariam Peter · Labiotech.eu_ The CEO of Therorna discusses the science of behind circular RNA and why Western pharma hasn't paid enough attention to what's being built in China. The post Why Western pharma is sleeping on China’s circular RNA revolution appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s…